• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜂王浆脂肪酸通过降低人肝癌 HepG2 细胞中 HNF4α 蛋白的表达来下调 ANGPTL8。

Royal jelly fatty acids downregulate ANGPTL8 expression through the decrease in HNF4α protein in human hepatoma HepG2 cells.

机构信息

Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, Japan.

Biomarker Laboratory, Research Institute for Production Development, Kyoto, Japan.

出版信息

Biosci Biotechnol Biochem. 2022 May 24;86(6):747-754. doi: 10.1093/bbb/zbac043.

DOI:10.1093/bbb/zbac043
PMID:35325025
Abstract

Royal jelly (RJ) intake has been reported to be effective for reducing serum lipids; however, the mechanism is not fully understood. Angiopoietin-like protein 8 (ANGPTL8), a secreted protein, plays a key role in lipid metabolism. In this study, we investigated the effects of specific fatty acids included in RJ (RJ fatty acids), such as 10-hydroxy-2-decenoic acid, 10-hydroxydecanoic acid, and sebacic acid (SA), on expression of ANGPTL8 in human hepatoma HepG2 cells. SA markedly reduced the expression of ANGPTL8. Reporter assay revealed that SA suppressed ANGPTL8 promoter activity. In addition, we identified a functional binding site of hepatocyte nuclear factor-4α (HNF4α), a liver-enriched transcription factor, in the ANGPTL8 promoter. SA reduced the levels of HNF4α protein and the binding of HNF4α to the ANGPTL8 promoter. Moreover, siRNA knockdown of HNF4α suppressed the expression of ANGTPL8 mRNA. Taken together, we conclude that SA downregulates ANGPTL8 expression via the decrease in HNF4α protein.

摘要

蜂王浆(RJ)的摄入已被报道可有效降低血清脂质;然而,其机制尚不完全清楚。血管生成素样蛋白 8(ANGPTL8)是一种分泌蛋白,在脂质代谢中发挥关键作用。在这项研究中,我们研究了 RJ 中所含的特定脂肪酸(RJ 脂肪酸),如 10-羟基-2-癸烯酸、10-羟基癸酸和癸二酸(SA),对人肝癌 HepG2 细胞中 ANGPTL8 表达的影响。SA 显著降低了 ANGPTL8 的表达。报告基因检测显示 SA 抑制了 ANGPTL8 启动子活性。此外,我们在 ANGPTL8 启动子中鉴定了一个功能性的肝富集转录因子肝细胞核因子 4α(HNF4α)结合位点。SA 降低了 HNF4α 蛋白水平和 HNF4α 与 ANGPTL8 启动子的结合。此外,siRNA 敲低 HNF4α 抑制了 ANGTPL8 mRNA 的表达。综上所述,我们得出结论,SA 通过降低 HNF4α 蛋白水平下调 ANGPTL8 的表达。

相似文献

1
Royal jelly fatty acids downregulate ANGPTL8 expression through the decrease in HNF4α protein in human hepatoma HepG2 cells.蜂王浆脂肪酸通过降低人肝癌 HepG2 细胞中 HNF4α 蛋白的表达来下调 ANGPTL8。
Biosci Biotechnol Biochem. 2022 May 24;86(6):747-754. doi: 10.1093/bbb/zbac043.
2
CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.CCAAT 增强子结合蛋白-α(C/EBPα)和肝细胞核因子 4α(HNF4α)调节人肝癌 HepG2 细胞中果糖-1,6-二磷酸酶 1(FBP1)基因的表达。
PLoS One. 2018 Mar 22;13(3):e0194252. doi: 10.1371/journal.pone.0194252. eCollection 2018.
3
Exo70 is transcriptionally up-regulated by hepatic nuclear factor 4α and contributes to cell cycle control in hepatoma cells.Exo70受肝细胞核因子4α转录上调,并有助于肝癌细胞的细胞周期调控。
Oncotarget. 2016 Feb 23;7(8):9150-62. doi: 10.18632/oncotarget.7133.
4
Angiopoietin-like 8 (ANGPTL8) expression is regulated by miR-143-3p in human hepatocytes.血管生成素样蛋白 8(ANGPTL8)的表达在人肝细胞中受 miR-143-3p 的调控。
Gene. 2019 Jan 10;681:1-6. doi: 10.1016/j.gene.2018.09.041. Epub 2018 Sep 24.
5
HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells.在人肝癌细胞中,HBx通过下调肝细胞核因子4α(HNF4α)来抑制细胞色素P450 2E1(CYP2E1)基因的表达。
PLoS One. 2014 Sep 19;9(9):e107913. doi: 10.1371/journal.pone.0107913. eCollection 2014.
6
Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.乙型肝炎病毒相关肝细胞癌中肝细胞核因子4α(Hnf4α)/微小RNA - 122(miR - 122)轴的表达降低增强了潜在致癌性GALNT10蛋白的活性。
J Biol Chem. 2015 Jan 9;290(2):1170-85. doi: 10.1074/jbc.M114.601203. Epub 2014 Nov 24.
7
Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.黄酮类化合物木犀草素作为转录因子肝细胞核因子4α抑制剂的鉴定。
J Biol Chem. 2015 Sep 25;290(39):24021-35. doi: 10.1074/jbc.M115.645200. Epub 2015 Aug 13.
8
Hepatocyte nuclear factor 4α (HNF4α) in coordination with retinoic acid receptors increases all-trans-retinoic acid-dependent CYP26A1 gene expression in HepG2 human hepatocytes.肝细胞核因子4α(HNF4α)与视黄酸受体协同作用,可增加全反式视黄酸依赖性CYP26A1基因在HepG2人肝细胞中的表达。
J Cell Biochem. 2014 Oct;115(10):1740-51. doi: 10.1002/jcb.24839.
9
Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats.饮食中链甘油三酯通过保护肝细胞核因子-4α减轻酒精诱导的大鼠肝脂代谢紊乱
Alcohol Clin Exp Res. 2013 Apr;37(4):587-98. doi: 10.1111/acer.12013. Epub 2012 Nov 5.
10
Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.分析新型代谢调节剂 ANGPTL8/Betatrophin 在人类癌症中的表达及预后潜能。
Pathol Oncol Res. 2021 Sep 27;27:1609914. doi: 10.3389/pore.2021.1609914. eCollection 2021.

引用本文的文献

1
Royal jelly acid: preparation, metabolism and therapeutic potential.蜂王酸:制备、代谢及治疗潜力
Front Pharmacol. 2025 May 26;16:1561351. doi: 10.3389/fphar.2025.1561351. eCollection 2025.
2
Medium-chain dicarboxylic acids: chemistry, pharmacological properties, and applications in modern pharmaceutical and cosmetics industries.中链二羧酸:化学、药理特性及其在现代制药和化妆品行业中的应用。
RSC Adv. 2024 May 28;14(24):17008-17021. doi: 10.1039/d4ra02598a. eCollection 2024 May 22.
3
Sebacic acid, a royal jelly-containing fatty acid, decreases LPS-induced IL-6 mRNA expression in differentiated human THP-1 macrophage-like cells.
癸二酸,一种含蜂王浆的脂肪酸,可降低脂多糖诱导的分化人THP-1巨噬细胞样细胞中白细胞介素-6 mRNA的表达。
J Clin Biochem Nutr. 2024 May;74(3):192-198. doi: 10.3164/jcbn.23-16. Epub 2023 Nov 22.
4
Role of the angiopoietin-like protein family in the progression of NAFLD.血管生成素样蛋白家族在非酒精性脂肪性肝病进展中的作用。
Heliyon. 2024 Mar 12;10(7):e27739. doi: 10.1016/j.heliyon.2024.e27739. eCollection 2024 Apr 15.